Baxter International | BAX - أصول متداولة





أصول متداولة تغيير تاريخ
Abbott USD 25.51B 488M 2026-03
AngioDynamics USD 161.35M 4.69M 2025-09
Artivion USD 371.38M 13.86M 2026-06
AtriCure USD 345.53M 31.84M 2026-06
Baxter International USD 6.99B 142M 2026-06
Becton, Dickinson and Co. USD 8.14B 127M 2026-06
Boston Scientific USD 7.97B 712M 2026-06
Cooper Companies USD 2.28B 18.3M 2026-06
Dexcom USD 4.09B 245.1M 2026-06
Edwards Lifesciences USD 6.82B 590.2M 2026-06
Fresenius EUR 11.61B 456M 2026-06
Globus Medical USD 2.22B 17.39M 2026-06
Halozyme Therapeutics USD 933.02M 70.01M 2026-06
ICU Medical USD 1.21B 2.34M 2026-06
Inogen USD 203.72M 594K 2025-09
Insulet USD 1.85B 139.6M 2026-06
Integra LifeSciences USD 1.19B 19.46M 2026-06
Intuitive Surgical USD 12.33B 807.5M 2026-06
J&J USD 59.77B 601M 2026-06
Laboratory Of America USD 3.81B 743.9M 2026-06
Medtronic USD 24.39B 397M 2026-06
Merit Medical Systems USD 1.11B 10.46M 2026-06
Quest Diagnostics USD 2.84B 278M 2026-06
Smith & Nephew USD 4.39B 240M 2026-06
Stryker USD 14.42B 1.08B 2026-06
Tandem Diabetes Care USD 804.64M 82.46M 2026-06
Teleflex USD 1.88B 16.21M 2026-06
Terumo JPY 906.6B 45.57B 2026-06
Zimmer Biomet Holdings USD 5.1B 134.2M 2026-06